Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas

Blood

Volumn 94, Issue 6, 1999, Pages 2080-2089

  Kossakowska, Anna E ^a   Edwards, Dylan R ^b   Prusinkiewicz, Christopher ^b   Zhang, Melissa C ^b   Guo, Dianlin ^b   Urbanski, Stefan J ^b   Grogan, Thomas ^b   Marquez, Leah A ^b   Janowska Wieczorek, Anna ^b  

^a FOOTHILLS HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0033567964     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.2080     Document Type: Article

References (66)

1. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for clinical usage. Cancer 49:2112, 1982.
2. Kossakowska AE, Hinek A, Edwards DR, Lim MS, Zhang Ch-L, Breitman DR, Prusinkiewicz C, Stabbler AL, Urbanski LS, Urbanski SJ: Proteolytic activity of human non-Hodgkin's lymphomas. Am J Pathol 152:565, 1998
3. Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR: Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res 5:19, 1993
4. Kossakowska AE, Urbanski SJ, Hutchcroft SA, Edwards DR: Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV Collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. Oncol Res 4:233, 1992
5. Kossakowska AE, Urbanski SJ, Edwards DR: Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood 77:2475, 1991
6. Kossakowska AE, Zhang MCh-L, Brasher P, Urbanski SJ, Edwards DR: TIMP-1 is a predictor of survival in human non-Hodgkin's lymphomas. Mod Pathol 12:140A, 1999
7. Murphy G: Matrix metalloproteinases and their inhibitors [Review]. Acta Orthop Scand Suppl 266:55, 1995
8. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G: Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751, 1997
9. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR: Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 73:1401, 1996
10. Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic (Review). Semin Cancer Biol 7:147, 1996
11. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG: Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood 89:1708, 1997
12. Matsuzaki A, Janowska-Wieczorek A: Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases. J Cancer Res Clin Oncol 123:100, 1997
13. Sawicki G, Matsuzaki A, Janowska-Wieczorek A: Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion. J Cancer Res Clin Oncol 124:245, 1998
14. Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Edwards DR, Kossakowska AE: Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: Comparison with normal bone marrow cells. Brit J Haematol 105:402, 1999
15. Mansoor A, Birkedal-Hansen B, Lim MS, Guedez L, Stetler-Stevenson WG, Stetler-Stevenson M: TIMP-1 expression correlates with histologic grade in B-cell lymphomas. Mod Pathol 10:130A, 1997
16. Hayakawa T, Yamashita K, Tanzawa E, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298:29, 1992
17. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M: In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 102:2002, 1998
18. Guedez L, Courtemanch L, Stetler-Stevenson M: Tissue inhibitor of metalloproteinase (TIMP-1) induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood 92:1342, 1998
19. Murphy G, Reynolds JJ: Extracellular matrix degradation, in Royce PM, Steinmann B (eds): Connective Tissue and its Heritable Disorders. New York, NY, Wiley-Liss, Inc, 1993, p 287
20. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity [Review]. J Immunol 156:1, 1996
21. Unemori EN, Hibbs MS, Amento EP: Constitutive expression of a 92-kDa gelantinase (type IV) collagenase by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656, 1991
22. Sato T, Ito A, Ogata Y, Nagase H, Mori Y: Tumor necrosis factor alpha (TNF alpha) induces pro-matrix metalloproteinase-9 production in human uterine cervical fibroblasts but interleukin 1 alpha antagonizes the inductive effect of TNF alpha. FEBS Lett 392:175, 1996
23. Kurogi T, Nabeshima K, Kataoka Y, Okada Y, Koono OM: Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via upregulation of fibroblast growth factor (FGF) receptor. Int J Cancer 66:82, 1996
24. Saren P, Welgus HG, Kovanen PT: TNF-alpha and IL-1 beta selectively induce expression of 92 kDa gelatinase by human macrophages. J Immunol 157:4159, 1996
25. Guedez L, Lim MS, Stetler-Stevenson WG: The role of metalloproteinases and their inhibitors in hematological disorders (Review). Crit Rev Oncog 7:205, 1996
26. Johnatty RN, Taub DD, Reeder SP, Turcovski-Corrales SM, Cottam DW, Stephenson TJ, Rees RC: Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 158:2327, 1997
27. Xia M, Leppert D, Hauser SL, Sreedharan SP, Nelson PJ, Krensky AM, Goetzl EJ: Stimulus specificity of matrix metalloproteinase dependence of human T-cell migration through a model basement membrane. J Immunol 156:160, 1996
28. Stüve O, Dooley NP, Uhm JH, Antel JP, Francis GS, Williams G, Yong VW: Interferon beta-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9. Ann Neurol 40:853, 1996
29. Di Girolamo N, Tedla N, Lloyd A, Wakefield D: Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol 28:1773, 1998
30. Barille S, Akhoundi C, Collette M, Mellerin MP, Rapp MJ, Harousseau JL, Bataille R, Amiot M: Metalloproteinases in multiple myeloma: Production of matrix metalloproteinase-9 (MMP-9), activation of pro MMP-2, and induction of MMP-1 by myeloma cells. Blood 90:1649, 1997
31. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM: Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 269:21322, 1994
32. Wahl LM, Corcoran ML: Regulation of monocyte/macrophage metalloproteinase production by cytokines. J Periodontol 64:467, 1993
33. Wang M, Fudge K, Rhim JS, Stearns ME: Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papilloma-virus-18 transformed human prostatic tumor cell lines. Oncol Res 8:303, 1996
34. Nuovo GJ: In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors and human papillomavirus transcripts in cervical carcinoma cell lines. Int J Cancer 71:1056, 1997
35. Sato T, Ito A, Mori Y: Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 170:824, 1990
36. Roeb E, Graeve L, Mullberg J, Matern S, Rose-John S: TIMP-1 protein expression is stimulated by IL-1 beta and IL-6 in primary rat hepatocytes. Ann N Y Acad Sci 762:462, 1995
37. Roeb E, Graeve L, Hoffman R, Decker K, Edwards DR, Heinrich PC: Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 18:1437, 1993
38. Stearns M, Wang M, Stearns ME: Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol Res 7:173, 1995
39. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC: Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. J Biochem 315:335, 1996
40. Lacraz S, Nicod L, Chicheportiche R, Welgus H, Dayer JM: 1L-10 inhibits metalloproteinases and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96:2304, 1995
41. The International Lymphoma Study Group: A Revised European-American Classification of Lymphoid Neoplasms: A Proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
42. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
43. Wong H, Anderson WD, Cheng T, Riabowol KT: Monitoring mRNA expression by polymerase chain reaction: The "primer-dropping" method. Anal Biochem 223:251, 1994
44. Voorzanger N, Toituou R, Garcia E, Delecluse HJ, Rousset F, Joab I, Favrot M, Blay JY: Interleukin (IL)-10 and IL-6 are produced in vivo in non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 56:5499, 1996
45. Janiak M, Hashmi HR, Janowska-Wieczorek A: Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Exp Hematol 22:559, 1994
46. Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ: Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 153:1895, 1998
47. Seymour JF, Talpaz M, Cabanillas F, Wetzler M, Kurzock R: Serum interleukin-6 levels correlate with prognosis in diffuse large cell lymphoma. J Clin Oncol 13:575, 1995
48. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J, Favrot MC: Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 82:2169, 1993
49. Cortes J, Kurzrock R: Interleukin-10 in non-Hodgkin's lymphoma [Review]. Leuk Lymphoma 26:251, 1997
50. Hirano T, Akira S, Taga T, Kishimoto T: Biological and clinical aspects of interleukin 6. Immunol Today 11:443, 1990
51. Hirano T: Interleukin-6 and its receptor: ten years later. Int Rev Immunol 16:249, 1998
52. Treon SP, Anderson KC: Interleukin-6 in multiple myeloma and related plasma cell dyscrasias [Review]. Curr Opin Hematol 5:42, 1998
53. Benjamin D, Knobloch TJ, Dayton MA: Human B-cell Interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289, 1992
54. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D: Interleukin-10 gene expression in adult T-cell leukemia. Blood 88:1035, 1996
55. Klein SC, van Wichen DF, Golverdingen JG, Jacobse KC, Broekhuizen R, de Weger RA: An improved, sensitive, non-radioactive in situ hybridization method for the detection of cytokine mRNAs. APMIS 103:345, 1995
56. Taga T, Kawanishi Y, Hardy RR, Hirano T, Kishimoto T: Receptors for B-cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med 166:967, 1987
57. Janowska-Wieczorek A, Marquez LA, Nabholtz J-M, Cabuhat ML, Montaño J, Chang H, Rozmus J, Russell JA, Edwards DR, Turner AR: Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane. Blood 93:3379, 1999
58. Matsuzaki A, Nabholtz J-M, Nahirniak S, Janowska-Wieczorek A: Endogenous erythropoietin, tumor necrosis factor-α and interleukin-6 levels after peripheral blood stem cell transplantation. Hematology 2:151, 1997
59. Mielcarek M, Roecklein BA, Torok-Storb B: CD14+ cells in granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral blood mononuclear cells induce secretion of interleukin-6 and G-CSF by marrow stroma. Blood 87:574, 1996
60. Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, Michiels JF, Van Damme J, Taga T, Kishimoto T, Crevon MC, Galanaud P: Interleukin-6 production in high-grade B lymphomas: Correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 80:498, 1992
61. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL: T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154:4379, 1995
62. Aoudjit F, Potworowski EF, St-Pierre Y: Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T-lymphoma/endothelial cell contact: Implication of ICAM-1. J Immunol 160:2967, 1998
63. Borden P, Heller RA: Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases [Review]. Crit Rev Eukaryot Gene Expr 7:159, 1997
64. Benbow U, Brinckerhoff CE: The AP-1 site and MMP gene regulation: What is all the fuss about? [Review]. Matrix Biol 15:519, 1997
65. Yoshizaki T, Sato H, Furukawa M, Pagano JS: The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci USA 95:3621, 1998
66. Tomeczkowski J, zur Stadt U, Reiter A, Welte K, Sykora KW: Absence of IL-6 receptor expression in fresh childhood Burkitt?s lymphoma cells and induction of IL-6 receptors by Epstein-Barr virus in vitro. Br J Haematol 97:400, 1997